Citations 1
Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study
Hobday, Timothy J. , Mahoney, M. R. , Erlichman, Charles , Lloyd, R, Kim, G., Mulkerin, Daniel , Fitch, Tom R., Donehower, Ross C. , Picus, Joel
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4083-4083
